KERATO offers a safe and permanent eye color change through a technique called keratopigmentation. This unique procedure permanently alters the natural eye color using a special pigment without causing intraocular complications, as per its self-described expertise in ophthalmology.

KERATO

NEORIS is a digital accelerator that provides tailored solutions for companies' digital transformation. NEORIS combines industry knowledge with technological expertise to address business challenges and promote growth.

NEORIS

Kerato is a UK-based biotech company that utilizes expertise in tissue engineering to develop bio-engineered corneal products for medical and research applications. It focuses on providing innovative solutions for corneal regenerative therapies and ocular toxicity testing.

Metric
Company Name	KERATO	NEORIS	Kerato
Symbol
MSH ID	COM:KERATO	COM:NEORIS	UK:CO:KERATO
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Technology	Healthcare & Health Services
Industry	Cosmetic and Aesthetic Services	Digital Consulting and IT Services	Biotechnology
Country	US	US	GB
Stage
Employee Count		5.00K
Website	kerato.com	neoris.com	kerato.co.uk
LinkedIn		neoris
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		32.15K
Web Traffic Growth		0.10
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:KERATO

KERATO

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue